Advertisement
News
Subscribe to MDT Magazine News

ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders

September 6, 2010 12:32 am | by Bio-Medicine.Org | Comments

ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming......

TOPICS:

Property Sales Give Biotech Brokers the Jitters

September 5, 2010 11:32 pm | by San Diego Business Journal | Comments

Experts say the recently announced purchase of three San Diego life sciences buildings by Alexandria Real Estate Equities Inc., already among the dominant players in local biotech real estate, marks a continuing trend toward consolidation, and could also signal a spree of acquisitions...

TOPICS:

Talented bacteria make food poisoning unpredictable

September 5, 2010 4:38 pm | by EurekAlert | Comments

(Society for General Microbiology) While we are often exposed to bacteria in our food which could cause food poisoning, we don't always become ill -- why should this be so? Professor Colin Hill who is presenting his work at the Society for General Microbiology's autumn meeting in...

TOPICS:
Advertisement

Older adults express anxiety in different ways

September 3, 2010 4:35 pm | by Baylor College of Medicine | Comments

While there are several factors that can cause anxiety in older adults, it can be difficult to identify because they express anxiety in unique ways, according to an expert at Baylor College of Medicine . Common types of anxiety disorders in older adults include generalized anxiety,...

TOPICS:

CDRH Touts Proposed 510(k) Changes as Good News for Device Industry

September 3, 2010 2:33 pm | by U.S. Food & Drug Administration | Comments

CDRH is trying to sell devicemakers on suggested changes to the 510(k) process, saying the changes would increase regulatory predictability.

Device Industry Has Much at Stake as Court Takes Up Matrixx Case

September 3, 2010 2:32 pm | by U.S. Food & Drug Administration | Comments

As the Supreme Court prepares to hear arguments in a shareholder lawsuit against Matrixx Initiatives, the device industry is bracing itself for a ruling that could dramatically increase the amount of information companies must provide to the public and change the FDA’s role in...

<i>Blog: </i>Shire launches Facebook page for Gaucher disease month

September 3, 2010 9:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Shire plc has launched a Facebook page in honor of National Gaucher Awareness Month – a move designed to link the name of the company, and the name of the rare disease its drug, VPRIV, is treating.

Pfizer ends brain cancer vaccine deal with Celldex

September 3, 2010 9:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Celldex Therapeutics Inc. has said Pfizer Vaccines LLC terminated its agreement with the Needham-based biotechnology firm to develop a potential brain cancer vaccine.

Advertisement

Mitsumi Prototypes MEMS Mirror With 10mW Power Consumption

September 3, 2010 9:33 am | by I-Micronews | Comments

According to Nikkei Electronics, Mitsumi Electric Co Ltd prototyped a MEMS mirror for laser projectors. The mirror is driven by using piezoelectric devices (PZTs), and a laser light is scanned to project an image.

TI expects shipments of DLP 3D Ready chips to reach 2-3 million units in 2011

September 3, 2010 9:33 am | by I-Micronews | Comments

According an article from Digitimes, Texas Instruments (TI) vice president of DLP business Kent Novak at a conference has commented that the company's shipments of DLP 3D Ready chips will increase to 2-3 million units in 2011, and the company already shipped over 300,000 from the fourth...

Polymer carpets - a new class of nanomaterials for NEMS and MEMS

September 3, 2010 9:33 am | by I-Micronews | Comments

Unlike most biological membranes, polymeric, nanometer-thin membranes are very stable and can withstand considerable pressure. This is an essential requirements for separation processes such as in water purification and desalination. Because their ...

China-Biotics Announces September 20 Investor Day Schedule

September 3, 2010 9:33 am | by Bio-Medicine.Org | Comments

China-Biotics Announces September 20 Investor Day Schedule -- SHANGHAI, Sept. 3 /PRNewswire-Asia-FirstCall/ --

TOPICS:

NACDS, NCPA: Victory for Patients, Pharmacy as CMS Moves to Withdraw Provisions of 'AMP' Rule Currently Blocked by Injunction

September 3, 2010 9:33 am | by Bio-Medicine.Org | Comments

ALEXANDRIA, Va., Sept. 3 /PRNewswire-USNewswire/ -- The following is a statement issued today by National Association of Chain Drug Stores (NACDS) President and CEO Steven C. Anderson, IOM, CAE, and National Community Pharmacists Association (NCPA) Acting Executive Vice President and CEO...

TOPICS:

Medical Affairs Report Outlines Resource Needs for Group Success

September 3, 2010 9:33 am | by Bio-Medicine.Org | Comments

CHAPEL HILL, N.C., Sept. 3 /- The Medical Affairs function arguably plays the most critical role in a biopharmaceutical organization, with heavy responsibilities across areas such as clinical development, scientific publications, KOL development, and medical education. These areas must...

TOPICS:

Pfizer ends deal with Celldex

September 3, 2010 9:32 am | by Mass High Tech: The Journal of New England Technology | Comments

Celldex Therapeutics Inc. has said Pfizer Vaccines LLC terminated its agreement with the Needham-based biotechnology firm to develop a potential brain cancer vaccine.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading